While there was a trend toward higher asprosin levels with increasing disease severity, this increase did not reach statistical significance in our cohort, highlighting potential variability due to comorbidities, age, or other patient-specific factors.
← all excerpts
Serum asprosin levels as a potential prognostic biomarker in COVID-19: insights for future respiratory viral pandemics.
1
—
—